Chromadex Corp
NASDAQ:CDXC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
NexTone Inc
TSE:7094
|
JP |
|
Keboda Technology Co Ltd
SSE:603786
|
CN |
|
Touchwood Entertainment Ltd
NSE:TOUCHWOOD
|
IN |
|
Zhong Yang Technology Co Ltd
TWSE:6668
|
TW |
Chromadex Corp
Total Current Liabilities
Chromadex Corp
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Chromadex Corp
NASDAQ:CDXC
|
Total Current Liabilities
$17.9m
|
CAGR 3-Years
1%
|
CAGR 5-Years
4%
|
CAGR 10-Years
14%
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Total Current Liabilities
$15.2B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
8%
|
CAGR 10-Years
14%
|
|
|
Danaher Corp
NYSE:DHR
|
Total Current Liabilities
$6.8B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
1%
|
|
|
Waters Corp
NYSE:WAT
|
Total Current Liabilities
$1.2B
|
CAGR 3-Years
16%
|
CAGR 5-Years
9%
|
CAGR 10-Years
8%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Total Current Liabilities
$2.2B
|
CAGR 3-Years
5%
|
CAGR 5-Years
6%
|
CAGR 10-Years
9%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Total Current Liabilities
$8.3B
|
CAGR 3-Years
14%
|
CAGR 5-Years
13%
|
CAGR 10-Years
18%
|
|
Chromadex Corp
Glance View
Chromadex Corp. is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. The company is headquartered in Los Angeles, California and currently employs 115 full-time employees. The company went IPO on 2007-06-25. NAD+ is a coenzyme and a regulator of cellular metabolism. The company operates through three segments: Consumer products, Ingredients, and Analytical reference standards and services segment. The Consumer products segment provides finished dietary supplement products that contain the ingredients directly to consumers as well as to distributors. The Ingredients segment develops and commercializes ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The Analytical reference standards and services segment supplies phytochemical reference standards and other research and development services. Its ingredients include Tru Niagen and Immulina. The Tru Niagen is a form nicotinamide riboside (NR). NR is a member of the vitamin B3 family. Immulina is a spirulina extract.
See Also
What is Chromadex Corp's Total Current Liabilities?
Total Current Liabilities
17.9m
USD
Based on the financial report for Dec 31, 2024, Chromadex Corp's Total Current Liabilities amounts to 17.9m USD.
What is Chromadex Corp's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
14%
Over the last year, the Total Current Liabilities growth was -13%. The average annual Total Current Liabilities growth rates for Chromadex Corp have been 1% over the past three years , 4% over the past five years , and 14% over the past ten years .
